Syndax Pharmaceuticals Stock Investor Sentiment
| SNDX Stock | USD 16.51 0.01 0.06% |
Slightly above 59% of Syndax Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Syndax Pharmaceuticals suggests that many traders are alarmed. Syndax Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Syndax Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Panic Vs Confidence
41
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Syndax Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Syndax Pharmaceuticals.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Syndax Historical Sentiment
Although Syndax Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Syndax, such as negative comments on social media and news outlets, may cause fear in the market and push Syndax Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Syndax.
Syndax |
Syndax Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Syndax Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Syndax Pharmaceuticals that are available to investors today. That information is available publicly through Syndax media outlets and privately through word of mouth or via Syndax internal channels. However, regardless of the origin, that massive amount of Syndax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Syndax Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Syndax Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Syndax Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Syndax Pharmaceuticals alpha.
Syndax Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Syndax Pharmaceuticals Navigating Through A Pivotal Year - Seeking Alpha | 09/20/2024 |
2 | Acquisition by Gallagher Neil of 69375 shares of Syndax Pharmaceuticals at 22.28 subject to Rule 16b-3 | 09/23/2024 |
3 | Syndax Pharmaceuticals Reports Q3 Loss, Tops Revenue Estimates | 11/05/2024 |
4 | Analysts Are Updating Their Syndax Pharmaceuticals, Inc. Estimates After Its Third-Quarter Results | 11/08/2024 |
5 | Syndax stock falls after leukemia drug data | 11/12/2024 |
6 | Scotiabank cuts SNDX stock target, keeps rating on FDA approval risk | 11/13/2024 |
7 | Simplify Asset Management Inc. Has 2.35 Million Position in Syndax Pharmaceuticals, Inc. | 11/15/2024 |
8 | STAT Syndax wins U.S. approval for leukemia treatment | 11/18/2024 |
9 | STAT Kura licenses leukemia drug to Japanese drugmaker | 11/20/2024 |
10 | Kura Oncology inks global deal with Kyowa Kirin | 11/21/2024 |
11 | Syndax Announces Participation at the Citi 2024 Global Healthcare Conference | 11/27/2024 |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.